CSIMarket Company Name, Ticker, Industry, else..
 
Neubase Therapeutics inc   (NASDAQ: NBSE)
Other Ticker:  
 
 

NBSE's Market share relative to its competitors, as of Q3 2023

As of Q3 2023 (Revenue in Millions of $)

Date modified: 2025-03-14T03:08:34+00:00



COMPANY NAME REVENUES
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months
Q3 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE
A Quarter Before
Q2 2023
Neubase Therapeutics inc 0.00 0.00% 0.00 % 0.00 %
Ionis Pharmaceuticals Inc 953.74 15.11% 17.29% 9.35%
Wave Life Sciences Ltd 108.30 1.72% 4.66% -0.60%
Sarepta Therapeutics Inc 1,901.98 30.13% 36.61% 36.55%
Prothena Corporation Public Limited Company 135.16 2.14% 0.12% 0.08%
Ptc Therapeutics inc 900.03 14.26% 10.36% 16.44%
Avid Bioservices Inc 150.54 2.38% 1.86% 3.14%
Verve Therapeutics Inc 32.33 0.51% 0.73% 0.54%
Design Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Exicure Inc 6.81 0.11% 0.00% 0.00%
Clene Inc 0.42 0.01% 0.00% 0.01%
Proqr Therapeutics N v 0.00 0.00% 0.00% 0.00%
Aileron Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Blueprint Medicines Corporation 508.82 8.06% 8.14% 10.03%
Stoke Therapeutics Inc 16.74 0.27% 0.27% 0.38%
Avidity Biosciences Inc 10.27 0.16% 0.12% 0.18%
Pieris Pharmaceuticals Inc 24.11 0.38% 0.00% 0.00%
Monopar Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Nucana Plc 0.00 0.00% 0.00% 0.00%
Aravive Inc 7.00 0.11% 0.15% 0.10%
Zymeworks Inc 76.30 1.21% 1.73% 1.25%
Oncosec Medical Incorporated 0.00 0.00% 0.00% 0.00%
Syros Pharmaceuticals Inc 23.44 0.37% 0.00% 0.00%
Regenerx Biopharmaceuticals inc 0.08 0.00% 0.00% 0.00%
Mersana Therapeutics Inc 40.50 0.64% 0.91% 0.99%
Provectus Biopharmaceuticals Inc 0.72 0.01% 0.01% 0.02%
Cns Pharmaceuticals Inc 0.03 0.00% 0.00% 0.00%
Kintara Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Hoth Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Soligenix inc 0.85 0.01% 0.00% 0.00%
Sonnet Biotherapeutics Holdings Inc 0.35 0.01% 0.00% 0.00%
Athenex Inc 102.82 1.63% 0.45% 2.62%
Mirati Therapeutics Inc 38.19 0.61% 0.91% 1.07%
Galera Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Abvc Biopharma Inc 0.52 0.01% 0.02% 0.01%
Lixte Biotechnology Holdings Inc 0.00 0.00% 0.00% 0.00%
Mei Pharma Inc 41.67 0.66% 0.00% 0.00%
Aprea Therapeutics Inc 0.00 0.00% 0.00% 0.04%
Cytokinetics Incorporated 18.47 0.29% 0.94% 0.04%
Corcept Therapeutics Inc 675.04 10.69% 10.11% 14.28%
Centessa Pharmaceuticals Plc 0.00 0.00% 0.00% 0.00%
Enanta Pharmaceuticals Inc 66.59 1.05% 0.94% 1.14%
Arrowhead Pharmaceuticals Inc 278.34 4.41% 0.14% 0.00%
Theratechnologies Inc 81.76 1.30% 1.30% 0.00%
Sagimet Biosciences inc 0.00 0.00% 0.00% 0.00%
Evelo Biosciences Inc 0.00 0.00% 0.00% 0.00%
Bio path Holdings inc 0.00 0.00% 0.00% 0.00%
Pulmatrix Inc 10.01 0.16% 0.02% 0.12%
Benitec Biopharma Inc 0.06 0.00% 0.00% 0.00%
Coya Therapeutics Inc 0.00 0.00% 0.00% 0.27%
Silence Therapeutics Plc 25.06 0.40% 2.36% 1.96%
Morphic Holding inc 75.30 1.19% 0.00% 0.00%
SUBTOTAL 6,312.35 100% 1,798.23 100%



NBSE's Market share relative to its competitors, as of Q3 2023 within the Major Pharmaceutical Preparations Industry
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Neubase Therapeutics inc 0.00% 0.00% 0.00 % 0.00 %
Ionis Pharmaceuticals Inc 15.11% 14.07% 17.29% 9.35%
Wave Life Sciences Ltd 1.72% 0.98% 4.66% -0.60%
Sarepta Therapeutics Inc 30.13% 29.85% 36.61% 36.55%
Prothena Corporation Public Limited Company 2.14% 2.43% 0.12% 0.08%
Ptc Therapeutics inc 14.26% 16.88% 10.36% 16.44%
Avid Bioservices Inc 2.38% 2.59% 1.86% 3.14%
Verve Therapeutics Inc 0.51% 0.44% 0.73% 0.54%
Design Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Exicure Inc 0.11% 0.02% 0.00% 0.00%
Clene Inc 0.01% 0.01% 0.00% 0.01%
Proqr Therapeutics N v 0.00% 0.00% 0.00% 0.00%
Aileron Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Blueprint Medicines Corporation 8.06% 8.01% 8.14% 10.03%
Stoke Therapeutics Inc 0.27% 0.28% 0.27% 0.38%
Avidity Biosciences Inc 0.16% 0.20% 0.12% 0.18%
Pieris Pharmaceuticals Inc 0.38% 0.40% 0.00% 0.00%
Monopar Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Nucana Plc 0.00% 0.00% 0.00% 0.00%
Aravive Inc 0.11% 0.17% 0.15% 0.10%
Zymeworks Inc 1.21% 1.13% 1.73% 1.25%
Oncosec Medical Incorporated 0.00% 0.00% 0.00% 0.00%
Syros Pharmaceuticals Inc 0.37% 0.46% 0.00% 0.00%
Regenerx Biopharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
Mersana Therapeutics Inc 0.64% 0.63% 0.91% 0.99%
Provectus Biopharmaceuticals Inc 0.01% 0.01% 0.01% 0.02%
Cns Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Kintara Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Hoth Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Soligenix inc 0.01% 0.01% 0.00% 0.00%
Sonnet Biotherapeutics Holdings Inc 0.01% 0.00% 0.00% 0.00%
Athenex Inc 1.63% 2.18% 0.45% 2.62%
Mirati Therapeutics Inc 0.61% 0.50% 0.91% 1.07%
Galera Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Abvc Biopharma Inc 0.01% 0.00% 0.02% 0.01%
Lixte Biotechnology Holdings Inc 0.00% 0.00% 0.00% 0.00%
Mei Pharma Inc 0.66% 0.74% 0.00% 0.00%
Aprea Therapeutics Inc 0.00% 0.00% 0.00% 0.04%
Cytokinetics Incorporated 0.29% 0.06% 0.94% 0.04%
Corcept Therapeutics Inc 10.69% 11.44% 10.11% 14.28%
Centessa Pharmaceuticals Plc 0.00% 0.00% 0.00% 0.00%
Enanta Pharmaceuticals Inc 1.05% 1.23% 0.94% 1.14%
Arrowhead Pharmaceuticals Inc 4.41% 4.43% 0.14% 0.00%
Theratechnologies Inc 1.30% 0.00% 1.30% 0.00%
Sagimet Biosciences inc 0.00% 0.00% 0.00% 0.00%
Evelo Biosciences Inc 0.00% 0.00% 0.00% 0.00%
Bio path Holdings inc 0.00% 0.00% 0.00% 0.00%
Pulmatrix Inc 0.16% 0.21% 0.02% 0.12%
Benitec Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Coya Therapeutics Inc 0.00% 0.00% 0.00% 0.27%
Silence Therapeutics Plc 0.40% 0.32% 2.36% 1.96%
Morphic Holding inc 1.19% 0.34% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



NBSE's Market share relative to its competitors, as of Q3 2023 within the Healthcare Sector
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Neubase Therapeutics inc 0.00% 0.00% 0.00 % 0.00 %
Ionis Pharmaceuticals Inc 15.11% 14.07% 17.29% 9.35%
Wave Life Sciences Ltd 1.72% 0.98% 4.66% -0.60%
Sarepta Therapeutics Inc 30.13% 29.85% 36.61% 36.55%
Prothena Corporation Public Limited Company 2.14% 2.43% 0.12% 0.08%
Ptc Therapeutics inc 14.26% 16.88% 10.36% 16.44%
Avid Bioservices Inc 2.38% 2.59% 1.86% 3.14%
Verve Therapeutics Inc 0.51% 0.44% 0.73% 0.54%
Design Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Exicure Inc 0.11% 0.02% 0.00% 0.00%
Clene Inc 0.01% 0.01% 0.00% 0.01%
Proqr Therapeutics N v 0.00% 0.00% 0.00% 0.00%
Aileron Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Blueprint Medicines Corporation 8.06% 8.01% 8.14% 10.03%
Stoke Therapeutics Inc 0.27% 0.28% 0.27% 0.38%
Avidity Biosciences Inc 0.16% 0.20% 0.12% 0.18%
Pieris Pharmaceuticals Inc 0.38% 0.40% 0.00% 0.00%
Monopar Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Nucana Plc 0.00% 0.00% 0.00% 0.00%
Aravive Inc 0.11% 0.17% 0.15% 0.10%
Zymeworks Inc 1.21% 1.13% 1.73% 1.25%
Oncosec Medical Incorporated 0.00% 0.00% 0.00% 0.00%
Syros Pharmaceuticals Inc 0.37% 0.46% 0.00% 0.00%
Regenerx Biopharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
Mersana Therapeutics Inc 0.64% 0.63% 0.91% 0.99%
Provectus Biopharmaceuticals Inc 0.01% 0.01% 0.01% 0.02%
Cns Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Kintara Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Hoth Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Soligenix inc 0.01% 0.01% 0.00% 0.00%
Sonnet Biotherapeutics Holdings Inc 0.01% 0.00% 0.00% 0.00%
Athenex Inc 1.63% 2.18% 0.45% 2.62%
Mirati Therapeutics Inc 0.61% 0.50% 0.91% 1.07%
Galera Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Abvc Biopharma Inc 0.01% 0.00% 0.02% 0.01%
Lixte Biotechnology Holdings Inc 0.00% 0.00% 0.00% 0.00%
Mei Pharma Inc 0.66% 0.74% 0.00% 0.00%
Aprea Therapeutics Inc 0.00% 0.00% 0.00% 0.04%
Cytokinetics Incorporated 0.29% 0.06% 0.94% 0.04%
Corcept Therapeutics Inc 10.69% 11.44% 10.11% 14.28%
Centessa Pharmaceuticals Plc 0.00% 0.00% 0.00% 0.00%
Enanta Pharmaceuticals Inc 1.05% 1.23% 0.94% 1.14%
Arrowhead Pharmaceuticals Inc 4.41% 4.43% 0.14% 0.00%
Theratechnologies Inc 1.30% 0.00% 1.30% 0.00%
Sagimet Biosciences inc 0.00% 0.00% 0.00% 0.00%
Evelo Biosciences Inc 0.00% 0.00% 0.00% 0.00%
Bio path Holdings inc 0.00% 0.00% 0.00% 0.00%
Pulmatrix Inc 0.16% 0.21% 0.02% 0.12%
Benitec Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Coya Therapeutics Inc 0.00% 0.00% 0.00% 0.27%
Silence Therapeutics Plc 0.40% 0.32% 2.36% 1.96%
Morphic Holding inc 1.19% 0.34% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Neubase Therapeutics inc's market divisions, geographic dispersion, segments, products, and services, visit Neubase Therapeutics inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com